Surgery News and Research

RSS

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £2.5 million through a rights issue to existing investors. The round was significantly oversubscribed and completed within four weeks.

9 Sep 2010

Hormone treatment with chemotherapy results in deadly side-effect in neuroblastoma children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

9 Sep 2010

JHN launches network to advance neuroscience care

Jefferson Hospital for Neuroscience (JHN) is launching the Jefferson Neuroscience Network (JNN) to promote collaboration among area hospitals to advance neuroscience care throughout the region. Chestnut Hill Hospital is the first hospital to join JNN. Through this collaboration, Jefferson and Chestnut Hill will provide the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.

9 Sep 2010

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

9 Sep 2010

BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft

BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.

9 Sep 2010

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun an important campaign that will reduce deaths from ovarian cancer.

9 Sep 2010

Scientists identify molecular marker to analyze chemotherapy response in breast cancer patients

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.

9 Sep 2010

Multi-resistant CNS bacteria spread in Sweden hospitals

Genetically closely related skin bacteria that have developed resistance to several different antibiotics and that can cause intractable care-related infections are found and seem to be spreading within and between hospitals in Sweden.

9 Sep 2010

Patients expects good long-term solutions for artificial hip system: Report

In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states,This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components.

9 Sep 2010

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

Competitive Technologies, Inc. announced today the publication of the detailed results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy (CIPN) using CTTC's Calmare® Pain Therapy Treatment

9 Sep 2010

ImmunoCellular Therapeutics announces long-term data from ICT-107 Phase I clinical trial for GBM

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

9 Sep 2010

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

Using a newly FDA approved pulmonary valve, Dr. Frank Ing, director of the catheterization laboratory at Texas Children's Hospital and his team of pediatric interventional cardiologists implanted a transcatheter pulmonary heart valve into the heart of a 13-year-old girl, which spared her from having her chest opened for a third heart surgery.

9 Sep 2010

Consumer Reports rates heart bypass surgical groups

The New York Times: Consumer Reports will rate groups that perform heart bypass surgery. The group already rates many consumer items like cars and even household appliances. "In most parts of the country, data-based ratings of doctors are not available to patients. Only a few states, including New York, provide them.

9 Sep 2010

BK Medical launches Flex Focus 700 mobile ultrasound system

Analogic Corporation, a leading provider of medical imaging and aviation security technology, announced today that its specialized ultrasound business, BK Medical, has introduced the Flex Focus 700™, a mobile ultrasound system designed primarily for ultrasound guided surgical procedures in the operating room.

9 Sep 2010

First Edition: September 8, 2010

In today's headlines, reports about how health reform is playing on the campaign trail and the latest on health insurance premium hikes.

8 Sep 2010

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

STAAR Surgical Company, the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable Collamer® Lens (ICL) was featured prominently in more than 40 presentations by leading ophthalmologists at meetings prior to and during the 2010 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) held in Paris, France from September 4 through 8, 2010.

8 Sep 2010

FDA clears Viking Systems' Next Generation 3DHD visualization system

Viking Systems, Inc. announced today that it has received clearance of its 510(k) application by the Food and Drug Administration related to its Next Generation 3DHD visualization system. The System is scheduled for market launch in Washington D.C. at this year's American College of Surgeons' Annual Clinical Congress which will be held from October 3-7.

8 Sep 2010

Study finds alternative birthing room reduces Caesarian section surgery

Giving birth in an alternative setting within a hospital like a bed-free birthing room or one designed to be "homelike" is just as safe for healthy women as laboring in a traditional hospital bed and women who use these rooms are nearly twice as likely to be satisfied with their birth experiences, according to an updated Cochrane review.

8 Sep 2010

Gemcitabine does not improve survival compared with fluorouracil plus folinic acid in resected pancreatic cancer

Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.

8 Sep 2010

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

An incisionless robotic surgical procedure is offering patients a new option to remove certain head and neck cancer tumors without visible scarring, while preserving speech and the ability to eat.

8 Sep 2010

Surgery News and Research

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

Hormone treatment with chemotherapy results in deadly side-effect in neuroblastoma children

JHN launches network to advance neuroscience care

'Beach envy' triggers enquiries for liposuction

BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft

BC gynecologists initiate campaign to reduce ovarian cancer mortality

Scientists identify molecular marker to analyze chemotherapy response in breast cancer patients

Multi-resistant CNS bacteria spread in Sweden hospitals

Patients expects good long-term solutions for artificial hip system: Report

CTTC's Calmare therapy effective against pain associated with chemotherapy-induced peripheral neuropathy

ImmunoCellular Therapeutics announces long-term data from ICT-107 Phase I clinical trial for GBM

Texas Children's Hospital implants FDA approved transcatheter pulmonary heart valve

Consumer Reports rates heart bypass surgical groups

BK Medical launches Flex Focus 700 mobile ultrasound system

First Edition: September 8, 2010

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

FDA clears Viking Systems' Next Generation 3DHD visualization system

Study finds alternative birthing room reduces Caesarian section surgery

Gemcitabine does not improve survival compared with fluorouracil plus folinic acid in resected pancreatic cancer

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News